Recalled Medicines & supplements – Current GIS Alerts 2026
Found 698 recalled products in the Medicines & supplements category. Check batch numbers, shops, and hazard information.
Common hazards in this category
All recalled products
Amikacin B.Braun
Cross-contamination of infusion solutions in the listed medicinal product batches was detected, which may mean the presence of incorrect substances in the medicine. Potential effects: poisoning, lack of treatment efficacy, serious complications.
Gentamicin B.Braun
Cross-contamination of infusion solutions was identified in numerous batches of B. Braun products, meaning the presence of incorrect active substances or their residues in bottles intended for intravenous administration, breaching quality and safety requirements. Potential effects: severe adverse reactions, poisoning, lack of efficacy or complications of intravenous therapy.
Gentamicin B.Braun
Cross-contamination of infusion solutions in the specified batches of B. Braun medicinal products was detected and reported in the Rapid Alert system by the Hessian State Office for Health and Care. Potential effects: risk of incorrect dosing, toxicity, lack of therapeutic efficacy or serious complications after intravenous administration.
Metronidazole B. Braun
Cross-contamination of infusion solutions in the listed batches of B. Braun medicinal products was detected. Potential effects: poisoning, severe adverse reactions, lack of therapeutic efficacy.
Ibuprofen B. Braun
Cross-contamination of infusion solutions in selected batches of medicinal products was found, which may result in administration of an unintended active substance to the patient and complications during intravenous treatment. Potential effects: poisoning, severe adverse reactions, lack of treatment efficacy.
Ibuprofen B. Braun
Cross-contamination of infusion solutions in the listed batches of B. Braun medicinal products was detected and reported via the Rapid Alert system by the German pharmaceutical authority. Potential effects: possible severe adverse reactions, poisoning, lack of therapeutic efficacy or infusion-related complications.
Ibuprofen B. Braun
Cross-contamination of infusion solutions was found in the listed batches of B. Braun medicinal products, reported via the Rapid Alert system by the Hessisches Landesamt für Gesundheit und Pflege as potentially endangering the safety of intravenous therapy. Potential effects: poisoning, severe adverse reactions, lack of efficacy, treatment complications.
Fluconazole B. Braun 2 mg/ml
Cross‑contamination of infusion solutions was detected in the above-mentioned medicinal product batches, which may lead to administration of an incorrect substance or dose to the patient. Potential effects: poisoning, serious adverse reactions, allergic reactions, lack of efficacy, severe systemic complications.
Paracetamol B. Braun
detection of cross-contamination of infusion solutions in the above-mentioned series of medicinal products Potential effects: poisoning, unpredictable adverse reactions, lack of therapeutic efficacy, perioperative complications.
Lactulose-MIP
A deviation in the manufacturing process was identified; deterioration of product quality during the shelf life cannot be excluded, thus creating a risk to patient health. Potential effects: lack of therapeutic efficacy or adverse reactions.
Lactulose-MIP
Deviations were identified in the product manufacturing process, so deterioration of its quality during the shelf life cannot be excluded, and therefore there is a potential risk to patient health. Potential effects: lack of treatment efficacy or unpredictable adverse reactions.
Sabril
Due to the detected presence of tiapride, a risk to the patient’s health or life cannot be excluded; the presence of trace amounts of tiapride may theoretically result in numerous serious and life‑threatening adverse reactions. Potential effects: severe, potentially life‑threatening adverse reactions.
Sabril
The presence of tiapride above 0.3 ppm in vigabatrin products may theoretically lead to numerous serious and life‑threatening adverse reactions; a risk to the patient’s health or life cannot be excluded. Potential effects: serious adverse reactions, including life‑threatening events.
Pasta borowinowa lecznicza
An excessive amount of Clostridium perfringens and the presence of Candida farmata/guilliermondii yeasts were detected, meaning the product does not meet microbiological purity requirements and may pose a health risk to patients when applied to the skin. Potential effects: skin infections, irritation, complications in immunocompromised individuals.
Tresuvi
Unidentified solid particles were detected in the solution for infusion; due to the unknown nature of the contamination, a risk to patients’ health and life cannot be excluded. Potential effects: thrombotic complications, emboli, inflammatory reactions, life-threatening events.
Andepin
Due to the detected increased content of a single impurity, a health risk for the patient taking this product cannot be excluded. Potential effects: poisoning, increased adverse reactions, complications of therapy.
Autostrzykawka Morfina Przeciwko Bólowi
Due to the detected solution discoloration that does not comply with quality requirements, the risk to the patient’s health and life cannot be excluded. Potential effects: poisoning, severe adverse reactions, life-threatening complications.
Sirdalud MR
It is not possible to guarantee specification-compliant active substance release after 2 hours until the end of the shelf-life, which may affect the quality and safety of product use. Potential effects: lack of treatment efficacy or increased adverse effects.
Sirdalud MR
It is not possible to guarantee specification-compliant release of tizanidine hydrochloride after 2 hours, and the cause is not fully understood, so the impact on product quality and safety of use cannot be predicted. Potential effects: lack of treatment efficacy or adverse effects related to incorrect dosing.
Detimedac 200 mg
The pink discoloration may be caused by degradation of the active substance, which may pose an increased risk to the patient. Potential effects: lack of treatment efficacy, complications of oncological therapy, possible adverse effects related to degradation products.
What to do if you bought a recalled product?
If you have purchased any of the products listed above, stop using or consuming them immediately. You can return the product to the store where you bought it for a full refund. Keep the receipt if possible, but most stores will accept returns even without one.